September 16, 2021

The implications of machine learning and biology in health care are remarkable. We’ve only begun to see what’s going to be possible over the next 10 years as biology transitions from its current state of exploration and discovery to one where we can actually engineer and predictably influence the financial industry and the biology of medicine.

Charles Huang, CEO and Professor of Hong Kong Graduate School of Advanced Studies, presented his latest researching findings on Finance and Biotech to the members of the Chinese Financial Association of Hong Kong.